We are live on ! Find out more
Grantham, Mayo, Van Otterloo & Co (GMO)

Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings

AUM $39.1B
1-Year Est. Return 28.69%
This Fund
S&P 500
This Quarter Est. Return
-1.68%
1 Year Est. Return
+28.69%
3 Year Est. Return
+71.15%
5 Year Est. Return
+97.93%
10 Year Est. Return
+429.41%
AUM
$39.1B
AUM Growth
-$26.3M
Cap. Flow
+$1.59B
Cap. Flow %
4.07%
Top 10 Hldgs %
39.91%
Holding
738
New
84
Increased
295
Reduced
215
Closed
110

Top Buys

Rank Stock Value
1
MA icon
Mastercard
MA
+$499M
2
SNPS icon
Synopsys
SNPS
+$411M
3
MSFT icon
Microsoft
MSFT
+$380M
4
NFLX icon
Netflix
NFLX
+$354M
5
CI icon
Cigna
CI
+$177M

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$546M
2
WFC icon
Wells Fargo
WFC
+$453M
3
PR
Permian Resources
PR
+$229M
4
ELV icon
Elevance Health
ELV
+$195M
5
NVDA icon
NVIDIA
NVDA
+$97.3M

Sector Composition

Rank Sector Weight
1 Technology 31.72%
2 Healthcare 23.65%
3 Communication Services 11.87%
4 Financials 10.29%
5 Consumer Discretionary 8.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.95T
$2.29B 5.85%
6,176,138
+908,452
+17% +$380M
GOOGL icon
2
Alphabet (Google) Class A
GOOGL
$4.24T
$1.98B 5.08%
6,900,577
+228,986
+3% +$71.9M
JNJ icon
3
Johnson & Johnson
JNJ
$603B
$1.78B 4.55%
7,278,866
+189,727
+3% +$44.2M
AAPL icon
4
Apple
AAPL
$4.81T
$1.76B 4.5%
6,937,574
+230,457
+3% +$60M
META icon
5
Meta Platforms (Facebook)
META
$1.63T
$1.76B 4.5%
3,073,041
+164,479
+6% +$105M
LRCX icon
6
Lam Research
LRCX
$403B
$1.48B 3.77%
6,904,206
-2,439,874
-26% -$546M
AMZN icon
7
Amazon
AMZN
$2.66T
$1.3B 3.32%
6,229,375
-124,038
-2% -$27.3M
TMO icon
8
Thermo Fisher Scientific
TMO
$195B
$1.23B 3.15%
2,502,206
+90,143
+4% +$48.9M
AVGO icon
9
Broadcom
AVGO
$1.84T
$1.04B 2.65%
3,348,517
+211,786
+7% +$69.7M
USB icon
10
US Bancorp
USB
$99.2B
$994M 2.54%
19,113,643
+712,639
+4% +$39.2M
TXN icon
11
Texas Instruments
TXN
$265B
$983M 2.51%
5,061,047
+173,227
+4% +$35.1M
V icon
12
Visa
V
$677B
$918M 2.35%
3,036,116
+386,559
+15% +$124M
ABT icon
13
Abbott
ABT
$174B
$915M 2.34%
8,910,945
+428,392
+5% +$48.4M
UNH icon
14
UnitedHealth
UNH
$396B
$855M 2.19%
3,158,451
+488,292
+18% +$145M
MRK icon
15
Merck
MRK
$312B
$844M 2.16%
7,013,777
+143,632
+2% +$16.6M
CRM icon
16
Salesforce
CRM
$139B
$826M 2.11%
4,425,552
+321,519
+8% +$66.6M
ACN icon
17
Accenture
ACN
$86.2B
$774M 1.98%
3,902,335
+281,066
+8% +$65.5M
CI icon
18
Cigna
CI
$76.8B
$693M 1.77%
2,598,218
+640,084
+33% +$177M
LLY icon
19
Eli Lilly
LLY
$1.05T
$690M 1.76%
749,815
+10,541
+1% +$10.7M
KLAC icon
20
KLA
KLAC
$284B
$679M 1.74%
4,612,020
-475,550
-9% -$69.6M
HLT icon
21
Hilton Worldwide
HLT
$73.7B
$675M 1.73%
2,219,281
-120,732
-5% -$36.6M
KO icon
22
Coca-Cola
KO
$353B
$630M 1.61%
8,279,748
-528,730
-6% -$40M
STZ icon
23
Constellation Brands
STZ
$22.3B
$604M 1.54%
4,025,780
+161,746
+4% +$25M
TJX icon
24
TJX Companies
TJX
$171B
$593M 1.52%
3,712,526
-85,993
-2% -$13.4M
ISRG icon
25
Intuitive Surgical
ISRG
$124B
$567M 1.45%
1,230,930
+45,020
+4% +$22.8M
1
2 3 4 5

Similar funds

Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
Empower Advisory Group
Empower Advisory Group Greenwood Village, Colorado $38.5B AUM 18.4% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q1 2026 Portfolio in Review

As of Q1 2026, Grantham, Mayo, Van Otterloo & Co (GMO) held 738 positions worth $39.1B, down 0.07% from $39.1B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Grantham, Mayo, Van Otterloo & Co (GMO) deployed $1.59B of net new capital in Q1 2026, opening 84 new positions and adding to 295 existing holdings. Its largest new stake was Synopsys: 910,133 shares worth $361M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 32% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Lam Research, an estimated $546M trimmed.

  • Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q1 2026 buy was Synopsys: 910,133 shares worth $361M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) added most to Mastercard in Q1 2026, an estimated $499M increase.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q1 2026 reduction was Lam Research, cutting an estimated $546M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) fully exited Comerica in Q1 2026, selling an estimated $36.8M.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 40% of its $39.1B portfolio in Q1 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) opened 84 new positions and closed 110 in Q1 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value fell 0.07% quarter-over-quarter to $39.1B.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.